NUTX
Nutex Health, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$193.24
−2.25%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 846.7M | 875.3M | 479.9M | 247.6M | 219.3M |
| Cost of Revenue | 412.7M | 431.0M | 283.7M | 212.9M | 203.9M |
| Gross Profit | 434.0M | 444.3M | 196.3M | 34.8M | 15.4M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 63.1M | 168.7M | 58.6M | 36.1M | 20.0M |
| General & Admin Expense | 63.1M | 168.7M | 58.6M | 33.2M | 20.0M |
| Selling & Marketing Expense | — | — | — | 2.8M | — |
| Other Expenses | 6.7M | — | 7.1M | 30.5M | 402.0M |
| Total Operating Expenses | 69.8M | 168.7M | 65.6M | 66.5M | 422.0M |
| Cost and Expenses | 482.5M | 599.6M | 349.3M | 279.4M | 625.9M |
| Operating Income (EBIT) | 364.3M | 275.6M | 130.6M | (31.8M) | (406.6M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 19.8M | 22.2M | 19.9M | 16.3M | 12.5M |
| Net Interest Income | (19.8M) | (22.2M) | (19.9M) | (16.3M) | (12.5M) |
| Other Non-Op Income/Expense | (20.8M) | (30.8M) | (20.9M) | (16.7M) | (13.0M) |
| Non-Operating Income (excl Interest) | 1.0M | 8.6M | 940.0K | 399.2K | 559.3K |
| EBT (Pre-Tax Income) | 343.5M | 244.8M | 109.7M | (48.5M) | (419.6M) |
| Income Tax Expense | 71.0M | 64.4M | 14.5M | (5.1M) | 13.1M |
| Bottom Line | |||||
| Net Income | 179.9M | 70.8M | 52.2M | (45.8M) | (424.8M) |
| Earnings from Cont. Ops | 272.5M | 180.4M | 95.3M | (43.4M) | (432.7M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 180.2M | 70.8M | 52.1M | (45.8M) | (424.8M) |
| Per Share | |||||
| Basic EPS | $26.23 | $11.13 | $10.23 | ($10.39) | ($100.50) |
| Diluted EPS | $25.28 | $10.48 | $9.71 | ($10.39) | ($100.36) |
| Revenue Per Share | $123.23 | $137.59 | $94.11 | $56.18 | $51.88 |
| Shares | |||||
| Basic Shares Outstanding | 6.9M | 6.4M | 5.1M | 4.4M | 4.2M |
| Diluted Shares Outstanding | 7.0M | 6.8M | 5.1M | 4.4M | 4.2M |
| Profitability Metrics | |||||
| EBITDA | 384.3M | 287.5M | 148.7M | (14.6M) | (394.0M) |
| D&A | 21.0M | 20.5M | 19.0M | 17.6M | 13.1M |
| EBIT | 363.3M | 267.0M | 129.7M | (32.2M) | (407.2M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026